4processed

Form 4 — Insider Transaction

KalVista Pharmaceuticals, Inc.(KALV)

Filing Date

June 11, 2026

Accepted

June 11, 2026

Accession No.

0001959750-26-000003

CIK

0001348911

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Arif BilalChief Operations OfficerOther100.0K0Stock Option (Right to Buy)Jun 11, 2026
Arif BilalChief Operations OfficerOther49.0K0Restricted Stock UnitJun 11, 2026